Archive · 31 Jul 2026
Piramal Pharma: Breakout Target, Tactical Trade Advice
A market expert named Halder talked about a drug company called Piramal Pharma.
He said the stock might go up to 238 rupees if it breaks through some price limits.
But he is not very excited about it and thinks it’s only good for a short trade.
He says investors should sell when the price rises because the company is small and not very liquid.
He also says there are better drug companies to invest in for longer gains.
So, he thinks Piramal Pharma is a quick trade, not a long‑term bet.
Halder sees a possible breakout to Rs 238 if resistance levels are broken.
He remains cautious, labeling the stock a tactical trade rather than a long‑term hold.
The expert advises investors to exit on rallies due to the company’s small size and liquidity.
Halder recommends looking at other pharma names with stronger trend durability for better opportunities.
The analysis focuses on capital allocation instead of target chasing.
- Who
- Halder, market analyst
- What
- Analysis of Piramal Pharma shares
- Why
- To advise investors on capital allocation and trading strategy
- Target price
- Rs 238
- Expert
- Halder
- Recommendation
- Tactical trade, exit on rallies
- Company
- Piramal Pharma
- Sector
- Pharma